Literature DB >> 27022729

Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report.

Zhao-Yu Lu1, Hai-Feng Yang2, Yu Peng1, Yin Li1, Zi-Chang Yin3, Fu-Hua Lu4, Xu-Sheng Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27022729     DOI： 10.1007/s11655-016-2098-1

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  21 in total

1.  Primary myelofibrosis in a patient who developed primary biliary cirrhosis, autoimmune hemolytic anemia and fibrillary glomerulonephritis.

Authors:  L I Kornblihtt; P S Vassalllu; P G Heller; N R Lago; C L Alvarez; F C Molinas
Journal:  Ann Hematol       Date:  2008-06-25       Impact factor: 3.673

2.  Fibrillary glomerulopathy.

Authors:  H R Brady
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

Review 3.  Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.

Authors:  B M Tune; S A Mendoza
Journal:  J Am Soc Nephrol       Date:  1997-05       Impact factor: 10.121

Review 4.  Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy.

Authors:  P H Pronovost; H R Brady; M E Gunning; O Espinoza; H G Rennke
Journal:  Nephrol Dial Transplant       Date:  1996-05       Impact factor: 5.992

5.  Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.

Authors:  A Fogo; N Qureshi; R G Horn
Journal:  Am J Kidney Dis       Date:  1993-09       Impact factor: 8.860

6.  Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.

Authors:  G C Yang; R Nieto; I Stachura; G R Gallo
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

8.  Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.

Authors:  Vincent Javaugue; Alexandre Karras; François Glowacki; Brigitte McGregor; Corinne Lacombe; Jean-Michel Goujon; Stéphanie Ragot; Pierre Aucouturier; Guy Touchard; Frank Bridoux
Journal:  Am J Kidney Dis       Date:  2013-06-04       Impact factor: 8.860

9.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Charles E Alpers; Jolanta Kowalewska
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

10.  Fibrillary glomerulonephritis and renal failure in a child with systemic lupus erythematosus.

Authors:  Shina Menon; Xu Zeng; Rudolph Valentini
Journal:  Pediatr Nephrol       Date:  2009-03-24       Impact factor: 3.714
View more
  2 in total

1.  The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children.

Authors:  Yan Jin; Yanzheng Wang; Sai Wang; Qiongqiong Zhao; Donghua Zhang; Xuan Feng
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-21       Impact factor: 2.629

Review 2.  Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis.

Authors:  Xue Wu; Youye Huang; Yao Zhang; Chunling He; Yongli Zhao; Lizhuo Wang; Jialin Gao
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.